DAIC

FEBRUARY 13, 2024

It further reported that these results underscore the strong and positive effect of the Cleerly products on clinical utility for patients with suspected coronary artery disease. “We He is the author of over 150 articles, book chapters, abstracts and other publications on advanced imaging technologies. 2023 Dec 12:jead339.

Coronary Artery Disease 103

Coronary Artery Disease Ischemia Atherosclerosis Cardiovascular Imaging 103

DAIC

DECEMBER 5, 2024

Cleerly is dedicated to creating a new standard of care for heart disease by using FDA-cleared solutions powered by artificial intelligence. Cleerly’s pioneering approach to advanced cardiovascular imaging, powered by AI-driven analysis, is elevating the field of diagnostic tools for coronary artery disease.

Coronary Artery Disease 52

Coronary Artery Disease Medicare Plaque Technology 52

DAIC

MARCH 28, 2025

v As cardiovascular disease (CVD) continues to rise globally, vi the need for advanced diagnostic technologies like cardiac CT angiography (CCTA) becomes increasingly critical. CCTA offers a non-invasive, cost-effective, and highly sensitive method for diagnosing coronary artery disease (CAD), making it a valuable tool for clinicians.

Technology 59

Technology Coronary Artery Disease Atrial Fibrillation Medicare 59

Frontiers in Cardiovascular Medicine

JUNE 30, 2024

ObjectiveThis study focuses on the innovative application of Automated Machine Learning (AutoML) technology in cardiovascular medicine to construct an explainable Coronary Artery Disease (CAD) prediction model to support the clinical diagnosis of CAD.MethodsThis study utilizes a combined data set of five public data sets related to CAD.

Coronary Artery Disease 52

Coronary Artery Disease Technology Innovation 52

DAIC

MARCH 27, 2025

In 2024, the FDA approved Flyrcado for patients with known or suspected coronary artery disease (CAD), delivering higher diagnostic efficacy compared to single-photon emission computed tomography (SPECT) i myocardial perfusion imaging (MPI), the predominant procedure used in nuclear cardiology today. 2023 Oct, 82 (16) 15981610.

Coronary Artery Disease 52

Coronary Artery Disease CMS Innovation Ischemia 52

DAIC

JUNE 18, 2024

Elixir Medical has announced the company’s novel bioadaptive implant, DynamX Sirolimus-Eluting Coronary Bioadaptor System, has been granted Breakthrough Device Designation by the U.S. After implantation, the locked phase establishes the maximum flow lumen and restores blood flow to treat symptoms of coronary artery disease (CAD).

Coronary Artery Disease 105

Coronary Artery Disease Technology Stents Stent 105

Medical Xpress - Cardiology

NOVEMBER 20, 2024

A new technology that allows doctors to quantify blood flow in the heart can improve their ability to diagnose potentially deadly coronary artery disease (CAD), an international study led by School of Medicine investigators has found.

Coronary Artery Disease 75

Coronary Artery Disease Technology 75

DAIC

JANUARY 23, 2024

a leader in non-invasive artificial intelligence (AI) precision coronary solutions, announced FFRCT was transitioned to a Category I Current Procedural Terminology (CPT) code beginning January 1, 2024. milla1cf Tue, 01/23/2024 - 13:44 January 23, 2024 — HeartFlow, Inc. ,

Reimbursement 105

Reimbursement Coronary Artery Disease CMS Technology 105

DAIC

MARCH 11, 2025

Food and Drug Administration (FDA) 510(k) clearance of its CaRi-Plaquetechnology, an AI-assisted image analysis application to aid the diagnosis of coronary artery disease (CAD). CaRi-Plaques precision and accuracy have been comprehensively validated against expert clinical consensus.

Plaque 52

Plaque Heart Attack Heart attacks Technology 52

DAIC

MARCH 1, 2024

Food and Drug Administration ( FDA ) approval for the AGENT Drug-Coated Balloon (DCB), which is indicated to treat coronary in-stent restenosis (ISR) in patients with coronary artery disease. Boston Scientific plans to launch the technology in the U.S. vs. 28.7%; P=0.006). in the coming months.

Stents 105

Stents Stent Coronary Artery Disease Angioplasty 105

DAIC

APRIL 12, 2024

a pioneering medical technology company specializing in cardiovascular interventional devices, today announced that its groundbreaking Acolyte Image Guided Crossing and Re-Entry Catheter System has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ).

Technology 111

Technology Cardiovascular Interventions Coronary Artery Disease Innovation 111

DAIC

MAY 8, 2024

1 Atherosclerosis is a systemic disease that affects multiple vascular regions and is particularly severe in PAD patients, where up to 80 percent suffer from concurrent coronary artery disease (CAD), historically linked with a mortality rate exceeding 50 percent within five years.

Coronary Artery Disease 111

Coronary Artery Disease Chest Pain Ischemia Myocardial Infarction 111

DAIC

JANUARY 17, 2024

With the continuous progress of science and technology, artificial intelligence (AI) has become an important driving force for a new round of scientific and technological revolution and industrial change. In recent years, the attempts of AI to run through the whole process of CCTA have expanded the application scope of CCTA.

Technology 111

Technology Coronary Artery Disease Cardiovascular Disease Cardiovascular Imaging 111

DAIC

JANUARY 3, 2024

6 Also in 2023, HeartFlow released its RoadMap Analysis which helps identify and quantify narrowings in the coronary arteries and has demonstrated a 25% faster CCTA read time. HeartFlow is committed to serving customers quickly and reliably with a median turnaround time less than 1.5

Coronary Artery Disease 59

Coronary Artery Disease Chest Pain Plaque Technology 59

DAIC

DECEMBER 19, 2023

The scanner combines the power and speed of dual-source CT technology—two X-ray tubes and two detectors—with embedded artificial intelligence and user assistance features to deliver workflow efficiencies. The optional FAST ( Fully Assisting Scanner Technologies ) 3D camera automatically performs precise, consistent patient positioning.

Chest Pain 104

Chest Pain Coronary Artery Disease Technology Outpatient 104

DAIC

JANUARY 25, 2024

mg tablets), together with Caristo Diagnostics , a leading cardiac disease diagnostics company with the novel CaRi-Heart technology to visualize and quantify coronary inflammation, announced today their collaboration to improve awareness and clinical education about the central role of inflammation in coronary artery disease.

Heart Attack 110

Heart Attack Heart attacks Technology Cardiovascular Disease 110

DAIC

MARCH 20, 2024

CLTI is the most severe form of peripheral arterial disease (PAD), estimated to affect 11% of the 200 million people suffering from PAD globally. degradation of magnesium observed 12 months after implantation in coronary arteries.4 2,3 It has shown 99.6% Jörg Pochert, President of Vascular Intervention at Biotronik.

Peripheral Arterial Disease 105

Peripheral Arterial Disease Innovation Technology Coronary Artery Disease 105

DAIC

MARCH 6, 2024

milla1cf Wed, 03/06/2024 - 18:48 March 6, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration ( FDA ) for its Coronary Artery Disease ( CAD ) Staging System.

Heart Disease 105

Heart Disease Heart Attack Heart attacks Technology 105

DAIC

MAY 31, 2024

Joaquin Duato , Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally.

Peripheral Arterial Disease 104

Peripheral Arterial Disease Innovation Coronary Artery Disease Cardiovascular Interventions 104

DAIC

JUNE 27, 2024

Attendees can join with their peers and participate in sessions on structural heart disease, congenital heart disease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, vascular heart disease, debates and games and early career topics. for all attendees.

Congenital Heart Disease 105

Congenital Heart Disease Coronary Artery Disease Congenital Heart Disease 105

DAIC

JULY 31, 2024

In its announcement about the workbook, ACC noted that cardiologists use digital devices and wearable technology to remotely monitor their patients for a variety of chronic cardiovascular diseases, including heart failure, coronary artery disease, vascular disease and atrial fibrillation.

Reimbursement 98

Reimbursement Technology Coronary Artery Disease Best Practices 98

MIBHS

FEBRUARY 28, 2025

A family history of heart disease often indicates that genetic factors might be at play. Common Heart Diseases with Genetic Links Coronary Artery Disease (CAD): CAD occurs when the arteries supplying blood to the heart become narrowed or blocked.

Genetic predisposition 52

Genetic predisposition Heart Disease Cholesterol Blood Pressure 52

DAIC

JUNE 25, 2024

milla1cf Tue, 06/25/2024 - 18:58 June 25, 2024 — Nano-X Imaging (Nanox), an innovative medical imaging technology company, today announced that data from five studies supporting the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox AI, will be presented at the 19th Annual Meeting of the Society of Cardiovascular Computed Tomography ( SCCT (..)

Coronary Artery Disease 105

Coronary Artery Disease Hospital Innovation Technology 105

DAIC

MARCH 27, 2024

The company reports this broadens the use of the novel bioadaptor platform technology beyond the treatment of coronary artery disease. The DynamX Bioadaptor platform is a medical technology designed to establish the new standard of care for vascular interventions, according to a written statement on the designation.

Peripheral Arterial Disease 111

Peripheral Arterial Disease Ischemia Technology Coronary Artery Disease 111

DAIC

JANUARY 15, 2024

FDA Breakthrough Device Designation recognizes novel innovations that demonstrate the potential to provide more effective treatment or diagnosis for life-threatening or irreversibly debilitating diseases.

Ultrasound 119

Ultrasound Coronary Artery Disease Innovation Heart Failure 119

DAIC

APRIL 5, 2024

With the addition of Shockwave, Johnson & Johnson will expand its MedTech cardiovascular portfolio into two of the highest-growth, innovation-oriented segments of cardiovascular intervention – coronary artery disease (CAD) and peripheral artery disease (PAD).

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

DAIC

MARCH 7, 2024

Computed Tomography (CT) continues to be a rapidly evolving technology with many new advancements, as displayed and discussed at the Radiological Society of North America109th Scientific Assembly and Annual Meeting (RSNA23). As a whole, the computed tomography market size in the US in 2024 is estimated to be $2.38

Technology 111

Technology Document Cardiovascular Imaging Cancer 111

DAIC

JANUARY 8, 2024

Recognizing the industry transformation taking place as digital innovation reshapes the experience of patients and providers, GE HealthCare – a leading global medical technology, pharmaceutical diagnostics, and digital innovator – is focused on developing smart devices, aligned to disease states and enabled by digital.

Innovation 105

Innovation Technology Patient Care Coronary Artery Disease 105

DAIC

JULY 25, 2024

mtaschetta-millane Thu, 07/25/2024 - 08:55 July 25, 2024 — Nanox, an innovative medical imaging technology company, announced that the AI Cardiac Solution (HealthCCSng) of its subsidiary, Nanox.AI was highlighted in multiple scientific presentations at the 2024 Society of Cardiovascular Computed Tomography (SCCT) Annual Meeting. “We

Innovation 105

Innovation Coronary Artery Disease Hospital Cardiovascular Disease 105

DAIC

MARCH 28, 2024

milla1cf Thu, 03/28/2024 - 07:00 March 28, 2024 — Cleerly , the company on a mission to create a new standard of care to aid in the diagnosis of heart disease, shared findings from a study published online in the Journal of the American College of Cardiology: Cardiovascular Imaging on March 13, 2024.

Ischemia 110

Ischemia Chest Pain Atherosclerosis Coronary Artery Disease 110

AMS Cardiology

MARCH 31, 2025

Coronary Artery Disease : Blocked arteries can affect heart function and rhythm. We offer comprehensive care plans tailored to each patient’s unique needs, utilizing the latest advancements in medical technology and treatment strategies.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Heart Rhythm Blood Pressure 52

DAIC

MARCH 20, 2024

Improved patient safety with reduced radiation and contrast load Enhancing patient safety is a pivotal aspect of advanced cardiac imaging technology. By employing advanced scanning technology, healthcare providers can ensure patients undergo diagnostic procedures with minimized risks.

Technology 111

Technology Coronary Artery Disease Patient Care Private Practice 111

DAIC

JUNE 12, 2024

Image courtesy: Philips christine.book Wed, 06/12/2024 - 14:07 June 12, 2024 — Royal Philips has announced its next-generation AI-enabled cardiovascular ultrasound platform to help speed up cardiac ultrasound analysis with proven AI technology and reduce the burden on echocardiography labs.

Ultrasound 105

Ultrasound Cardio Oncology Technology Congenital Heart Disease 105

DAIC

MAY 23, 2024

REVEALPLAQUE aimed to evaluate HeartFlow’s non-invasive plaque technology , an automated, deep learning-based method for identifying, characterizing, and segmenting plaque in the coronary arteries. 1 Heart disease is the leading cause of death for both men and women.² co-principal investigator and and K.

Plaque 52

Plaque Coronary Artery Disease Technology Anatomy 52

DAIC

MARCH 13, 2024

milla1cf Wed, 03/13/2024 - 16:52 March 13, 2024 — In the largest randomized clinical trial and first of its kind to date in the United States, a team led by investigators at Beth Israel Deaconess Medical Center (BIDMC) assessed the efficacy and safety of using a drug-coated balloon in patients undergoing coronary angioplasty. and Susan F.

Stents 116

Stents Stent Angioplasty Myocardial Infarction 116

Cardiometabolic Health Congress

AUGUST 2, 2024

The Omics Revolution: Powering Precision Nutrition Omics technologies form the backbone of genetically tailored nutrition, providing unprecedented insights into the molecular intricacies of human biology: Genomics : Unraveling the DNA blueprint to identify genetic variations that influence nutrient metabolism and dietary responses.

Diet 59

Diet Technology Coronary Artery Disease Quality of Life 59

Frontiers in Cardiovascular Medicine

JANUARY 7, 2024

Introduction The use of contemporary drug-eluting stents (DES) has significantly improved outcomes of patients with coronary artery disease (CAD) undergoing percutaneous coronary intervention (PCI).

Stents 64

Stents Stent Cardiogenic Shock Coronary Artery Disease 64